Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis
Open Access
- 14 September 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (9) , 2320
Abstract
Fibrin clot structure and function are major determinants of venous and arterial thromboembolic diseases, as well as the key determinants of the efficiency of clot lysis. Studies have revealed that fungi fibrinolytic compound 1 (FGFC1) is a novel marine pyranisoindolone natural product with fibrinolytic activity. Here, we explore the impacts of FGFC1 on clot structure, lysis, and plasminogen activation in vitro using turbidimetric, enzyme-linked immunosorbent assay, confocal and electron microscopy, urokinase, or plasmin chromogenic substrate. Clots formed in the presence of FGFC1 expressed reduced fibrin polymerization rate and maximum turbidity; however, they did not influence the lag phase of fibrin polymerization. In the absence of scu-PA (single-chain urokinase plasminogen activator), microscopy revealed that FGFC1 increased the number of protofibrils within fibrin fiber and the pore diameter between protofibrils, inducing clots to form a region of thinner and looser networks separated by large pores. The effects of FGFC1 on scu-PA-mediated plasma clot structure were similar to those in the absence of scu-PA. In addition, FGFC1 promoted the lysis of clots and increased the D-dimer concentration in lysate. FGFC1 increased the generation rate of p-nitroaniline in plasma. These results show that FGFC1 has fibrinolytic activity in plasma, leading to interference with the release of fibrinopeptide B to affect lateral aggregation of protofibrils and increase clot susceptibility to fibrinolysis by altering its structure.Keywords
Funding Information
- National Natural Science Foundation of China (81750110548, 19440741200, 17490742500)
- Shanghai Innovation Action Plan (81750110548, 19440741200, 17490742500)
- the Scientific Research Project of Shanghai International Science and Technology Cooperation Fund Project (81750110548, 19440741200, 17490742500)
This publication has 45 references indexed in Scilit:
- Fibrinolysis and the control of blood coagulationBlood Reviews, 2015
- Mechanisms of fibrin polymerization and clinical implicationsBlood, 2013
- Fibrin Clot Structure and FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2011
- Fibrinopeptides A and B release in the process of surface fibrin formationBlood, 2011
- Dynamic imaging of fibrin network formation correlated with other measures of polymerizationBlood, 2008
- Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary AtherothrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlledBiophysical Journal, 1992
- Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UKBiochemistry, 1992
- Effective activation of the proenzyme form of the urokinase‐type plasminogen activator (pro‐uPA) by the cysteine protease cathepsin LFEBS Letters, 1992